Renovia Inc., a healthcare based investment firm has only been in operation for two years as it was established on August 2016. Nevertheless, in its two years of existence, the firm has marked milestones that companies which have been in play longer than that, aren’t even close to accomplishing. Its success can be attributed to its great leaders, led by Marc Beer.
Profitable investments that impact the lives of others positively
Having been in the healthcare sector all his life, Marc Beer boasts vast experience in the field of biotechnology, pharmaceuticals and several other areas of MedTech. This has helped him identify some of the most profitable areas to venture in, and this when combined by the many networking connections he boasts, has enabled him turn many of Renovia’s goals into a reality. It’s also essential to note that these investments benefit not only him, but impact the rest of the world positively as well.
For instance, under his direction, and that of the other two founding members of Renovia Inc., namely; Yolanda Lorie and Ramon Iglesias, Renovia Inc developed the first pelvic training device known as Leva. The primary objective for the development of the leva device is to improve the lives of more than 250 million women who suffer from pelvic disorders such as urinary incontinence after childbirth.
Marc Beer does it again
Marc Beer has once again brought triumph to Renovia Inc. after he led the company to secure a whopping $42.3 million, during its series B round founding. Again he achieved this through his top-shelf networking abilities. Once again the funding was inclusive of A-list healthcare investment firms such as Longwood, Ascension ventures, New York perceptive advisors and many others.
The primary purpose of the funding is to facilitate the development of a new generation Leva device which will further curb the prevalence of pelvic disorders. The funds will also be channeled to the development of three more diagnostic and therapeutic products which again, will help shape the health industry.
More insight into Marc Beer
Marc Beer has been at the helm of medical technology for more than two years now. His innovative skills when it comes to ground-breaking biotech and pharmaceutical developments has seen him be part of multiple MedTech giants. For instance, in his over 25 years career, Marc has served as Vice president of Genzyme’s global marketing team, where he helped facilitate the launch of products that address rare diseases. He was also an executive member of Erytech Pharma’s board of directors and also worked at Abbot Pharmaceuticals.
Marc Beer’s career path shows his outstanding leadership skill and commitment in the pharmaceutical field. Early 2000, he was appointed as the founding chief executive officer of ViaCell. The biotechnology company grew tremendously under his leadership managing to employ over three hundred workers. ViaCell Company mainly specializes in collecting umbilical cord blood stem cell, preserving and developing. After working for five years, Marc managed to move ViaCell Company publicly by 2005; two years later it was acquired by PerkinElmer.
Erytech Pharma appointed Mark as one of the boards of director members while working at ViaCell. Before he had joined ViaCell, he previously worked for the Genzyme. He used his expertise in sells and marketing in launching the company products. He has also served for many companies as founding chairman including Good Start Genetics, Minerva Neuroscience and as the advisory council of Miami University. Marc Beer is a graduate of Miami University with a bachelor of science degree.
His vast experience and expertise in pharmaceutical, biotechnology, innovation, and disease diagnosis were motivating factors to partner with Dr. Pulliam, Roman Iglesias, and Yolanda Lorie and started their company, Renovia. Mark shows the compassion in his duty by raising $42 million for finding the solution with regards to women health. He uses his innovation to find a product that will cure pelvic floor disorders.
The Pelvic floor disorders are as the result of the injury or weakening of the ligament, tissue and pelvic muscle. The condition is caused by the prolapse of the bladder, the urethra, rectum, and small intestine. Renovia Medtech Company is fully committed in research and find a product to diagnose the disorders. They estimate to reach around 250 million women across the globe. The company is looking for an exclusive way to train patient and strengthen the weak pelvic floors muscle while the patient is alone at home by investing in leva pelvic digital health system. Leva is their first product, and by April FDA approved it.
Leva product is visualized with technology that trains the patient to control urination. It has motion sensor technology that shows a vaginal profile of a woman when at rest or during movement, it is programmed to measure the time one requires during training, and it is easy for a patient to track and do a subsequent reading and share data using this technology. With the leva treatment, one requires no surgeries.
The funding from the Long wood is going to be used in developing of four products. Mark during an interview noted that the Renovia Company is appreciating the investors who willing are offering support to Boston based Medtech and it is so committed to provide treatment and change millions of lives of pelvic floor disorders patient in the world. Learn more: https://www.linkedin.com/in/marcbeer
If you are a young adult or teenager, you surely wouldn’t forget listening to “closer” and “selfie” on repeat after they were released. Rings a bell right away? Well, the songs by Chainsmokers were so hit that almost every other person loved listening to them. You want to know the person behind the amazing generation and production of the song? It was Alex Pall, along with his partner Andrew Taggart. Let’s get to know what Alex Pall stated in the interview about his passion for music and how he hopped in.
Alex Pall’s hobby was DJing. He grew up doing it at different places in New York. While he was working on his career, he always used to be more inclined towards music. He was not only playing music as the side work, but he was truly passionate about it. Though for him it was scary to pursue something that was more fun than a job. But then a moment of realization made his life turn upside down, Alex was at an art gallery when he realized that music and dance were overwhelming him, not mere as a hobby but like a complete ignited passion. Alex wanted to give it a proper shot and so he went for it, his manager introduced him to Drew, he then quit his job, moved from Maine and started working over the first song. That was where the generation of the band Chainsmokers started.
Alex and drew got together every day, shared what they were working on, the relentless effort led them to what Chainsmokers is today. Alex and drew both shared the same kind of passion for music. Alex believes that people understand their music on a more profound level. For him, it’s a constant flight of self-discovery and knowing things better and better. Alex believes that by trying new things you stay in the loop and discover even greater things that you wouldn’t have even ever imagined of.
Renovia Inc. is a startup organization that was founded by Marc Beer. Renovia is an organization in the pharmaceutical industry. The company will be moving forward with its new products that deal with pelvic floor disorders after it closed at $32 million Series B round. In addition to this, the company closed with another ten million in business debt. Renovia is located in Boston, and the company is coming up with several diagnostic and therapeutic products meant to cure pelvic floor disorders such as urinary incontinence. According to researchers, the disorder is affecting more than 250 million women around the globe. The first product of Renovia received approval from FDA in April. Longwood fund also joined Series B round too. Learn more: https://renoviainc.com/leadership/
Longwood is an organization that invests in companies that are dealing with healthcare. The organization is under Perspective Advisor in New York as well as Ascension Ventures base in Missouri. The funding will be used to create and testing four other diagnostic and therapeutic products including Leva device’s new generation. Marc Beer claimed that they were happy to have such partners who are ready to fund the shared vision to diagnose correctly, as well as treat, and enhance the lives of millions of women across the world who are suffering from pelvic floor disorders. By bringing together the company’s proprietary and innovative sensor technologies, the organization will be able to create elements with a digital health platform that will provide its clients with information about the company’s new treatment options.
In addition to this, the platform will allow the clients to get a better understanding of the disorders of the pelvic floor. Moreover, it will help the customers to be able to lower the costs of long-term health care. Renovia forms the first organization that Marc Beer has come up with since he left Aegerion. Marc has brought great talent to the organization since it was started in 2016. He believes that with this great team, the organization will soar high in terms of success in the coming years.
Marc takes his time to recruit the best of the best into his organization, a fact that gives him confidence that they will reach their goals. He believes that Renovia is the leader when it comes to the healthcare of women as well as in the digital health. Marc acknowledges the fact that there were earlier breakthroughs in peripheral vascular disease, pain management, and cardiac disorders. But there had never been such a breakthrough in women healthcare and digital healthcare until Renovia came into existence. Marc goes ahead to say that he knows that there will be more breakthroughs in the area in the future. According to Marc, all organizations require capital efficiency and resource allocation, and this is what has seen Renovia to its current state. Follow Marc Beer on LinkedIn
Pelvic floor dysfunction refers to the inability to tighten the pelvic floor muscles when having a bowel movement. The symptoms include urine leakage and constipation to mention a few. Treatments include biofeedback, surgery, and medication. Biofeedback allows the therapist to evaluate how the patient relaxes their pelvic muscles via special sensors after which the therapist will observe your coordination. Surgery is useful in loosening your affected pelvic floor organs if it’s rooted in rectal prolapse, a disorder that causes the rectal tissue to fall in your anal opening. In medication, your doctor will prescribe a muscle relaxer to prevent your muscles from contracting. But, most individuals suffering from pelvic floor disorders cannot access these treatment methods. Therefore, scientists, entrepreneurs, and donors have collaborated to finance the treatment. One such individual is Marc Beer. Learn more: https://www.slideshare.net/MarcBeer
Marc Beer’s Contribution
Marc Beer is the CEO of Renovia Inc. He is a talented entrepreneur with a problem-solving acumen for business. He has been transforming businesses into strong financial vehicles through strategic policies. The recent funding of $42 million for a biotechnology start-up Marc Beer co-founded has spoken about his reputation for transforming small businesses to successful companies with a reputable future. The collected funds will be used to finance the research and drug development of pelvic floor disorders since it’s an international healthcare problem that affects millions of women.
The Fund Raiser
The funds were raised by an infusion strategy that saw the start-up receive donations from various investment companies including Ascension Ventures and Longwood Fund. This donation will be used to improve the development of Revia, a fully FDA approved drug used to treat pelvic floor disorders. Marc Beer hopes that the new round of Series B Funding will catapult the company towards perfecting the diagnosis systems for pelvic floor disorders by partnering with revolutionary patient-based technologies that have valuable data. He also hopes that it will contribute to a reduced overhead cost for treating urinary incontinence.
Marc Beer is a business generator, motivational speaker and the co-founder of Renovia. He combines dynamism with charisma to generate a force to improve businesses. He marshals his resources to develop startups into useful businesses. He consistently looks out for challenges to find viable solutions and opportunities for the less fortunate. Over the years, he’s garnered experience from various companies including ViaCell where he was the CEO. In his tenure, the company succeeded in stem cell research thereby earning a stellar reputation in NASQAD. The employee base grew tremendously.
Beer is a business developer with extensive experience in sales, marketing, and pharmacy. Prior to joining the startup origination industry, he was the vice president of Genzyme, an international marketing company. He has a degree in science from Miami University.
The age of technology has brought a significant number of technological devices that individuals can use to monitor and control their health is changing the health industry. People can now monitor their health problems in a consistent manner, which will help them to understand the characteristics of their conditions. Understanding the basic characteristics of a disorder helps the doctors or other medical physicians to provide a solution to the ailment in a simple and cost-effective strategy. Renovia Inc. is one of the technology-based medical companies that are providing advanced medical devices to monitor the health of an individual.
The company, which was founded in 2016 by Marc Beer and other health experts has come up with an innovative device that helps in monitoring and controlling pelvic floor disorders such as urinary inconsistency. Pelvic floor disorders are a group of rare medical conditions that are affecting a significant number of women around the world. Current statistics indicate that more than two hundred and fifty million women in the United States and other parts of the world are experiencing a medical condition that is associated with pelvic floor disorder.
Multiple studies continue to highlight that there has no exhaustive method of diagnosing pelvic floor disorders such as urinary inconsistency and pelvic floor pain, which has caused a large number of women to remain with untreated health problems, which can mutate to more complex health conditions such as cancer. In the worst case, many women are diagnosed with the wrong health problem, which means that they consume the wrong drugs. Therefore, there is a necessity for a company to specialize in these conditions and bring up the necessary health conditions, which will help in eliminating or controlling these conditions.
Marc Beer has brought one of the most innovative technological methods that will assist in diagnosing and treating pelvic floor disorders. However, the project had been interrupted by a significant lack of funds to produce the products in large quantities so that people around the world can access them with ease. Through the influence of Marc Beer, Renovia Inc. has been able to marshal funds from different sources either through donations or loans. The medical company received around $32 million from healthcare investors such as The Longwood and other interested organizations. The other remaining amount, $10 million, was secured through venture debts.
About Marc Beer
Marc Beer is the co-founder of Renovia Inc., a technology-based medical company that provides innovative solutions to pelvic floor disorders. Marc also acts as the Chief Executive Officer of the medical company, which he co-founded with other medical experts with the aim of eliminating or controlling the rare conditions. Pelvic floor disorders have been affecting a significant number of women around the world, without a real solution to counter the effects of these disorders. Learn more: https://www.slideshare.net/MarcBeer
Marc Beer is a healthcare pioneer and is skilled in the development and commercialization of patient therapies. He has served for companies such as Erytech Pharma,and was Vice President of Global Marketing at Genzyme. He holds a BS from Miami University and over 25 years of experience generating business success for pharmaceutical corporations through his knowledge of the specifics of pharmaceutical marketing. Marc has been crucial in the marketing of several different products used to treat complicated diseases and conditions. He is a strong leader and extremely dedicated to bringing great products to the market with extreme success. With all this experience, it is not surprising to find out that Marc is now at the forefront of pharmaceutical innovation. Sometimes the best way to perfect a company is to start your own. In August 2016 Marc co-founded Renuvia, Inc., and now serves as the CEO. Renuvia will have an impact on roughly 250 million women worldwide by developing new treatments for pelvic floor diseases. Marc successfully raised $32 million through fundraising, with another $10 million in venture capital funds.
Thanks to funding which came from the healthcare-focused investment firm The Longwood Fund, Renovia will begin testing on 4 new therapeutic and testing products. These advanced concepts will feature proprietary sensors and form factors that will allow doctors to provide the best, most accurate therapy based on an individual’s specific conditions and symptoms. This will all be used within a digital health platform so patient data remains consistent, and everyone has a better knowledge and understanding of pelvic floor diseases. Doctors working together to treat a patient can better collaborate through this platform. This could ultimately lead to lower healthcare costs, since more accurate treatments could be developed the first time, rather than a patient having to come back and try different treatments.
Marc Beer has already has a very successful healthcare career, and he isn’t just devoted to his own personal suucess. It is clear that Marc has a very strong sense of compassion for individuals dealing with complicated, life-altering, difficult to treat diseases. It is without a doubt that Renuvia will see the same suuccess that Marc has seen from his other ventures. Learn more : https://www.slideshare.net/MarcBeer
Marc Beer is the incumbent President and Chief Executive Officer of Renovia Company. He has a rich experience of over 26 years in the production, enhancement, and commercialization of biopharmaceutical, biotechnological and diagnostic products. He founded Renovia in the year 2010 in collaboration with Ramon Iglesias, Yolanda Lorie, and William Dull.
He previously worked at Algerian Pharmaceuticals serving as its Chief Executive Officer. Aegerian is a pharmaceutical industry that is focused on the production and commerce of ultramodern products for patients with rare infections. He enabled the firm to go public in the year 2010.
The firm produced its trademark product, JUXTAPID, in the year 2012. The product gained approvals in over 35 countries all around the world. Earlier in the year 2012, it was certified by the American Board of Drugs and Food Administration.
Marc Beer also cofounded Viacell corporation in early 2000. The company is a biopharmaceutical corporation that collects, stores develops umbilical cord cells. He has been the manager in the firm for more than six years. Under his leadership, the company experienced remarkable success. In the year 2005, the firm was publicly traded out. He also increased the company’s employees to a record 300.
Due to his immense expertise and managerial qualities, he has been appointed to senior most leadership positions in several firms. He was a director at Erytech Pharma’s board. Erytech is a leading public limited biotechnology company. He also served as Global Marketing’s vice president. As the company’s vice president it was required of him to launch the trade of medical products targeting significant diseases.
Marc Beer confirmed Longwood’s funding recently. In a statement, he said the investment would go along way in dealing with pelvic disorders all around the world. Longwood is one of the leading healthcare foundations. The firm primarily invests in medical courses across the globe.
Longwood pumped a hefty $32 million into Renovia’s program. It also invested an additional $10 million to cover debt ventures. The Boston situated pharmaceutical company is currently producing medical products aimed at the alleviation of pelvic disorders. Marc noted that urinary incontinence is a significant disease affecting over 250 million women worldwide.
Marc Beer further added that Renovia was committed to launching the innovation of additional therapeutic and diagnostic products such as the modern Leva gadget. He also maintained that the company would utilize its sensor technologies and innovative measures to deal with major pelvic disorders at a reduced cost.
Marc’s role in the pharmaceutical industry has been phenomenal. He incorporates technology in the production of useful medical products. Due to his role played in the biopharmaceutical world, he has been honored with multiple awards. His reputation is also held in high regard amongst his partners at work and his clients. Learn more : https://www.slideshare.net/MarcBeer
The Australian Financial Review recently recognized the Infinity Group Australia as one of the top 100 most innovative companies of the year. The company was originally founded by Graeme Holm back in 2013 along with his business partner, Rebecca Walker and, ever since its inception, it’s become one of the fastest-growing companies in the nation. It is also noted for its philanthropic endeavors as the company seeks to help countless people in Australia get themselves out of debt, improve their current financial situations and ensure their futures are financially secure. As it happens, this is now the seventh year that the company has made it on this list. This particular list names the most innovative companies throughout Australia and New Zealand and is the only one of its kind in the entire country.
This particular publication reaches around 1.8 million readers across the country. This year’s list was judged by Inventium, one of Australia’s leading consultaing firms, who compiled the list alongside a panel of experts on industry and business growth. Some of the categories they look at include how well they are able to address the problem they’re attempting to resolve, the quality of the solution and how well it works in the real world, innovation, culture, strategy and many others. IGA was selected from over 1,000 companies throughout the country and came in at number 58.
Their founder, Graeme Holm, graciously accepted this honor at the awards ceremony on July 30, 2018, where he expressed his gratitude to the Australian Financial Review for this award and noted how grateful he felt to be given this honor. Given their position on the list, they rank in the top 5.8% of all the companies selected for this particular honor. He also thanked his team for their constant dedication and hard work as well as his partner, Rebecca Walker. Holm has obtained over 15 years of financial experience in the financial industry and is dedicated to keeping banks and other financial institutions morally upright and honest. He also has a personal commitment to helping families who are struggling financially to keep their heads above water.
This passion and dedication are what eventually inspired him to create his own company which has since become a leader in the financial industry. The company is currently based out of Bella Vista, New South Wales which is located in Sydney. IGA is constantly expanding and finding more ways to help as many people as they can. Their commitment to philanthropy and the wellness of others is what has led to their success as they manage to eliminate about $41,000 of debt per year. So we congratulate them on this honor and wish them the best. Learn more : http://meetgraemeholm.com.au
Graeme Holm and Rebecca Walker founded Infinity Group Australia in 2013, and the company has become one of Australia’s most innovative companies. The company focuses on helping Australians to reduce their debt and improve their financial outlook. Just a half decade after its creation the company has made a list put together by the Australian Financial Review that points to it as one of the Most Innovative Companies in 2018. The list has been published for 7 years, now, and is a unique list that works to highlight companies from different industries. Companies were judged by how well they solved the problems of their customers or clients, and the quality of the help they gave them also came under close inspection.
Out of 1,000 companies in Australia, Infinity Group Australia was ranked 58th, and Graeme Holm showed up to accept the award while attending the 2018 AFR Most Innovative Companies List Awards Night. He commented that his company was proud to have made the list and thanked the groups responsible for putting his company in the running for the honor. He went on to congratulate his team and called them out for their passion and ability to be innovative in the financial industry. Holm, himself, has done quite a bit to build the company, and a lot of its mission was inspired by his desire to protect Australians from the big banks that were not really helping them as much as they could.
Infinity Group Australia is headquartered in Bella Vista, New South Wales in Sydney and is expanding at a rapid pace. Graeme Holm has been recognized as one of the MPA Top 100 Brokers in Australia and has been honored with other awards over the years. His company remains committed to producing results for its customers, and every single customer they have served has paid more off of their home loan in 3 months that they were able to do in a year before they came to Holm and Infinity Group Australia for help.
Graeme Holm has been working in the financial services industry for more than 17 years and is accredited in real estate, financial planning, and finance. Before serving with Infinity Group Australia, he worked in the major 4 banking environment. After becoming more and more fed up with how Australian families were being treated by the Big four, he decided to offer them help directly. Holm studied at Illawarra Christian School and went on to earn an a Master’s of Business Administration while studying at the Australian Institute of Business.
Graeme Holm believes that ideas and people are better and stronger when they work together in a collaborative way. At his company, employees are encouraged to offer their opinions through a suggestion box and collaboration with other professionals is also encouraged. He believes when an idea is implemented quickly it can help more people. He has also commented that even the best of ideas are nothing if there isn’t a solid group of people who are working together to implement it. Learn more : http://meetgraemeholm.com.au/